West Pharma (WST) Reports In-Line Q4 EPS; Issues Lightish FY14 Profit Outlook
Tweet Send to a Friend
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.38, in-line with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
